The present invention relates to anilinopyrazole derivatives, methods for
the preparation of such anilinopyrazoles, and use of such
anilinopyrazoles in the treatment of certain diseases or conditions. In
particular, the present invention relates to a nilinopyrazole derivatives
useful as CDK2 inhibitors and use of the anilinopyrazoles in the
treatment of disorders mediated by inappropriate CDK2 activity.